2021-11-16-世界卫生组织-Cervical_cancer_Qatar_2021_country_profile_1页_65kb

Qatar's cervical cancer profile indicates a relatively low burden of disease. Morbidity and mortality are characterized by a crude incidence of 3.2 per 100,000 women in 2020, standardized incidence at 4.1, cumulative risk of 0.5%, and 1,500 deaths in 2019, with a mortality-to-incidence ratio of 0.48. A population-based cancer registry is in place.

Primary prevention focuses on HPV vaccination, launched in 2020 with coverage around 2-2% among girls aged 9-14, and data indicates low tobacco use prevalence and low HIV incidence.

Secondary prevention includes a national screening program using cytology for women aged 21-65, with 41% screened in the last five years, and efforts to strengthen early detection at primary care levels.

Treatment involves existing national guidelines, radiography, chemotherapy, and supportive care options, though data shows variability in resource availability.

WHO elimination targets for 2030 aim to improve indicators like higher vaccine coverage and screening rates, with ongoing data collection noted.